Syra Health Corp.
SYRA
$0.17
$0.0431.54%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 73.31% | 45.89% | 95.43% | 67.36% | 49.32% |
| Total Depreciation and Amortization | 102.57% | -199.83% | -68.09% | 40.32% | -306.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.52% | 2,493.94% | -65.66% | -158.18% | 248.53% |
| Change in Net Operating Assets | -179.04% | 22.85% | 81.58% | 3.30% | 132.44% |
| Cash from Operations | -34.70% | 40.89% | 95.18% | 119.76% | 87.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 16.95% | 17.06% | 16.77% | 9.31% | 90.32% |
| Issuance of Common Stock | -- | -100.00% | -- | -98.26% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.95% | -105.61% | 16.77% | -108.26% | -101.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.76% | -129.86% | 88.76% | 326.13% | -109.26% |